Effects of the dual peroxisome proliferator–activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes
Erdmann, Erland, Califf, Robert, Gerstein, Hertzel C., Malmberg, Klas, Ruilope, Luis, Schwartz, Gregory G., Wedel, Hans, Volz, Dietmar, Ditmarsch, Marc, Svensson, Anders, Bengus, MonicaVolume:
170
Language:
english
Journal:
American Heart Journal
DOI:
10.1016/j.ahj.2015.03.021
Date:
July, 2015
File:
PDF, 173 KB
english, 2015